Crinetics (CRNX) is up 12.8%, or $5.86 to $51.81.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- Crinetics 7.62M share Secondary priced at $45.95
- Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
- Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
- Crinetics announces $350M common stock offering
- Crinetics price target raised to $97 from $85 at JonesResearch